Research Article

Chronic Hyperinsulinaemic Hypoglycaemia in Rats Is Accompanied by Increased Body Weight, Hyperleptinaemia, and Decreased Neuronal Glucose Transporter Levels in the Brain

Table 2

Antibodies used for western blotting.

TransporterPrimary antibody
(cat. number)
CompanyWorking
dilution
Size of band(s)
detected (kDa)
Blocking peptide
(cat. number)
Host species of
primary antibody
Secondary
antibody dilutiond

GLUT107-1401MLSa1:800043N/ARabbit1:3000
GLUT3ab15311Abcamb1:40038, 45, and 50N/ARabbit1:1500
SGLT1ab14686Abcam1:100030, (42)ab190911Rabbit1:2000
MCT1AB3540PMLSa1:500040N/ARabbit1:4000
ActinAb1801Abcam1:100010, 25, 30, and 42cab13771Rabbit1:2000

N/A, not applicable as the corresponding blocking peptide was not commercially available; instead, one was custom synthesized (CASLO ApS, Kgs. Lyngby, Denmark) according to the peptide sequence supplied by the manufacturer of the primary antibody. All custom-synthesized blocking peptides were supplied at >95% purity. aMerck Life Science A/S, Hellerup, Denmark. bAbcam plc., Cambridge, UK. cTriple band. dThe same secondary goat anti-rabbit (#170-6515, Bio-Rad Laboratories, Copenhagen, Denmark) was used for all primary antibodies.